LENNHAM PHARMACEUTICALS
Lennham Pharmaceuticals is dedicated to improving the metabolic and pharmacological profile of drugs through deuterium chemistry. The companies approach has yielded significantly improved products with strong patent protection by identifying chemical compounds that could benefit from a modification to their metabolic or pharmacokinetic properties, generating experimental data to determine if deuterium chemistry can influence one or more metabolic or pharmacokinetic properties and support broad patent protection, and advancing products with a high probability of clinical success and significant commercial potential.
LENNHAM PHARMACEUTICALS
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2019-01-01
Address:
Concord, Massachusetts, United States
Country:
United States
Website Url:
http://www.lennham.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
2.33 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Content Delivery Network Squarespace Squarespace Add To Cart
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Current Employees Featured
Founder
Official Site Inspections
http://www.lennham.com
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Lennham Pharmaceuticals"
Lennham Pharmaceuticals
At Lennham, we strive to improve the metabolic and pharmacological profile of drugs through deuterium chemistry. We are a team of industry experts who believe that deuterium chemistry …See details»
Lennham Pharmaceuticals - Crunchbase Company Profile & Funding
View contacts for Lennham Pharmaceuticals to access new leads and connect with decision-makers. Lennham Pharmaceuticals is a pharmaceutical company that helps to improve the …See details»
Lennham Pharmaceuticals - Org Chart, Teams, Culture & Jobs
View Lennham Pharmaceuticals' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Lennham Pharmaceuticals - LinkedIn
Lennham Pharmaceuticals | 138 followers on LinkedIn. Improving the metabolic and pharmacological profile of drugs through deuterium chemistry | We believe that deuterium …See details»
Lennham Pharmaceuticals - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Lennham Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
Lennham Pharmaceuticals
May 17, 2021 · Lennham is a privately held, clinical-stage life sciences company focused on the creative application of deuterium chemistry to highly utilized and well-characterized …See details»
Lennham Pharmaceuticals - Contacts, Employees, Board Members, …
Lennham Pharmaceuticals helps to improve the metabolic and pharmacological profiles of drugs through deuterium chemistry.See details»
Lennham Pharmaceuticals
Interested in partnering? Reach out. 53 Main Street, Suite 206. Concord, MA 01742.See details»
Lennham Pharmaceuticals - Funding, Financials, Valuation
Lennham Pharmaceuticals helps to improve the metabolic and pharmacological profiles of drugs through deuterium chemistry.See details»
Lennham Pharmaceuticals - Overview, News & Similar companies
May 30, 2022 · Who is Lennham Pharmaceuticals. Lennham is a privately held, life sciences company focused on the creative application of deuterium chemistry to highly utilized and well …See details»
Lennham Pharmaceuticals Announces Discovery of …
Nov 10, 2021 · Founded in 2019, Lennham’s unique approach to deuteration has enabled it to rapidly develop a pipeline of patent-protected product candidates, including deuterium-enhanced forms of caffeine,...See details»
Lennham Pharmaceuticals - VentureRadar
At Lennham, we strive to improve the metabolic and pharmacological profile of drugs through deuterium chemistry. Our pipeline offers significant... ... Find out more about Lennham …See details»
Lennham Pharmaceuticals - Crunchbase
Lennham Pharmaceuticals helps to improve the metabolic and pharmacological profiles of drugs through deuterium chemistry.See details»
Lennham Pharmaceuticals Announces Topline Results from …
Jun 7, 2021 · Lennham is a privately held, clinical-stage life sciences company focused on the creative application of deuterium chemistry to improve upon highly utilized and well …See details»
Lennham Pharmaceuticals
Deuterium (D) is a naturally occurring, stable isotope of hydrogen (H), with an additional neutron in its nucleus. Selectively substituting hydrogen with deuterium, or deuteration, is a way to …See details»
Lennham Pharmaceuticals Announces Issuance of U.S. Patent …
May 31, 2022 · Founded in 2019, Lennham’s unique approach to deuteration has enabled it to rapidly develop a pipeline of product candidates, including deuterium-enriched forms of …See details»
Lennham Pharmaceuticals
Sep 10, 2021 · Lennham Pharmaceuticals Expands Leading Psilocybin Patent Portfolio with Addition of New Patent FamilySee details»
Lennham Pharmaceuticals
Lennham has discovered that selective deuteration of caffeine can significantly extend its half-life. We have demonstrated these results in both human and rat studies. Rats showed an 80% …See details»
BRADFORD SIPPY - CEO @ Lennham Pharmaceuticals - Crunchbase
BRADFORD SIPPY has 2 current jobs as Chairman & CEO at Tremeau Pharmaceuticals and CEO at Lennham Pharmaceuticals. Additionally, BRADFORD SIPPY has had 2 past jobs …See details»
Lennham Pharmaceuticals
Our pipeline offers significant clinical & commercial potential coupled with a strong patent portfolio.See details»